revealed grade II bilateral sacroiliitis. Human leukocyte antigen B27 was positive. Liver and kidney function tests were normal. Lactic acid dehydrogenase was 229 U/L, upper of normal limits. Hemoglobin was 9.6 gm/dL; the patient had iron deficiency anemia. Serum angiotensinconverting enzyme level was 10.7 U/L (normal 8.0-52). His human immunodeficiency virus status was negative. F-18 FDG PET/CT revealed multiple hypermetabolic malignant lymphadenopathies at gastrohepatic, gastrosplenic, celiac, superior mesenteric, peripancreatic and hepatobiliary region, and paragastric region in size as 18 × 15 mm (SUV max : 12.3) and diffuse gastric wall thickening as linitis plastica (SUV max : 13.3), multiple hypermetabolic peritoneal implants in the omentum (SUV max : 5.7) and peritoneum, and mild hypermetabolic suspected malignant lymph nodes at left supraclavicular region (Fig. 1) . Gastric ulcer at incisura angularis was detected on upper GI endoscopy (Fig. 2) . Endoscopic biopsies were repeated for histopathological and microbiological differential diagnosis. Histopathological examination showed granulomatous gastritis, Langhans-type giant cells, granulomas composed of epithelioid histiocytes, ulceration, and exudates in the two samples. Real-time TB-PCR were negative, Erlich-Ziehl-Neelsen staining bacteria were negative. Gastric fluid examination revealed Gram-positive cocci, Gram-positive bacillus, and no leukocytes. Exploratory laparotomy was done to sample the biggest sized lymph nodes for tissue diagnosis and explore the peritoneum for TB infection, lymphoma, and Crohn's disease to make differential diagnosis. During laparotomy, the abdomen and peritoneum were intact and normal; two lymph nodes were extracted for histopathological and microbiologic diagnosis. Histopathology of the lymph nodes extracted by exploratory laparotomy revealed granulamatous lymphadenitis with granulomas including giant cells, mostly suspecting TB (Fig. 3) . Ankylosing spondylitis was also diagnosed. Bath ankylosing spondylitis disease Patient was put on ATT consisting of (2HREZ/7HR) regimen as isoniazid, rifampicin, ethambutol, and pyrazinamide at therapeutic doses for initial 2 months followed by rifampicin and isoniazide in the same doses for the last 7 months. At the 6th week of treatment, he gained weight about 6 kg and he was feeling healthy. Hemoglobin was 12.6 gm/dL. We performed follow-up F-18 FDG PET/ CT. The F-18 FDG PET/CT images (maximum intensity projection, CT, and fusion PET/CT) exhibited a complete response to ATT with no residual disease (Fig. 4) . We have taken written informed consent from the patient reported in this study.
DISCUSSION
In the GI tract, abdominal TB can be seen in any part of the GI system. The most commonly seen clinical manifestation of abdominal TB is abdominal lymphadenopathy. The most commonly involved parts of the GI tract are the ileocecal region and ascending colon. Isolated gastric TB is so rare and its diagnosis is mostly challenging.
1
The lesions may be in different forms like ulcerative, proliferative, or ulceroproliferative. The proliferative and ulceroproliferative forms of the disease may come in view like a mass mimicking GI tract cancer even on advanced imaging evaluations and may show intense uptake on F-18 FDG PET/CT imaging. 2 In our case, we performed F-18 FDG PET/CT evaluation for the differential diagnosis suspecting gastric cancer or lymphoma. In daily practice, oncologic evaluation is mostly done for staging, detection of recurrence, or extension of malignant diseases, and F-18 FDG PET/CT imaging is not specific for diagnosis of cancer. Although F-18 FDG PET/CT is not sensitive for granulomatous diseases like TB, it is helpful for the clinicians in the evaluation of suspected or known TB cases. 3 In cases of active TB, they mostly exhibit a high degree of FDG uptake in different degrees due to the grade of inflammatory activity. 4 
F-18 FDG PET/CT evaluation
is highly sensitive for inflammation and infection, but it has a poor sensitivity for these conditions. The combined use of F-18 FDG and C-11 acetate may help to differentiate inflammation from neoplasms because C-11 accumulates in tumors but not in the inflammatory lesions. 5 Martinez et al 6 evaluated F-18 FDG-PET/CT as a noninvasive method for early therapeutic response in TB. In this study, lower SUV max at month 1 of treatment is mentioned as a marker of early improvement with ATT and helps the clinicians to confirm TB diagnosis. In our case, we performed a follow-up F-18 FDG-PET/CT at 10th month of therapy to confirm our diagnosis and evaluate the success of ATT. Follow-up F-18 FDG PET/CT exhibited a complete response to ATT with no residual disease. In the literature, there are quite enough reports about F-18 FDG PET/CT findings of abdominal TB and radiological findings of isolated gastric TB but there is no report about F-18 FDG PET/CT findings of isolated gastric TB. 7 According to our knowledge, our case report should be the first report about F-18 FDG PET/CT findings in the diagnosis of isolated gastric TB. F-18 FDG PET/CT may provide help in the diagnosis and follow-up of isolated gastric TB in challenging cases.
